Brevan Howard Capital Management’s Amicus Therapeutics FOLD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$560K Buy
+97,688
New +$560K ﹤0.01% 1222
2025
Q1
Sell
-18,266
Closed -$172K 1217
2024
Q4
$172K Sell
18,266
-26,094
-59% -$246K ﹤0.01% 901
2024
Q3
$474K Buy
44,360
+31,185
+237% +$333K ﹤0.01% 640
2024
Q2
$131K Buy
+13,175
New +$131K ﹤0.01% 896
2015
Q3
Sell
-65,500
Closed -$927K 27
2015
Q2
$927K Buy
+65,500
New +$927K 0.29% 26